This morning, another 14 diabetes patients in California filed suit in the Los Angeles Superior Court, bringing the count of Californiavictims filing suit to over 115. Nationwide, there have been over 1,000 lawsuits to date.

These complaints allege the manufacturer, Takeda Pharmaceuticals, and their distributor, Eli Lily, “concealed and failed to completely disclose their knowledge that Actos was associated with or could cause bladder cancer or their knowledge that they had failed to fully study and test regarding that risk and, further, made conscious decisions to ignore the association between the use of Actos and pioglitazone hydrochloride and the risk of developing bladder cancer.” 

Many of these lawsuits, such as 5 new lawsuits filed in Los Angeles Superior Court today, are wrongful death claims initiated by surviving family members. Common claims are that a loved one took Actos for over a year in order to control their type 2 or “lifestyle” diabetes and died of bladder cancer while on the drug.

Studies show that there is as much as a 40% increase in getting bladder cancer after taking Actos for a year or longer.  Due to these often repeated results, the U.S. Food and Drug Administration (FDA) has issued a public health warning that using this drug could increase your chances of getting bladder cancer.  Thousands of patients claim to have been injured by Actos. 

Over 20% of the diabetes medication prescribed today is Actos.  Since 2007, it is the most commonly prescribed drug in the world for treating type-2 diabetes.  In America alone, it is the 10th most prescribed drug. That’s a lot of diabetics at risk for developing bladder cancer.

Injured patients have been filing suit across the United States seeking relief for their injuries.  If you’ve developed bladder cancer after taking Actos, you may be entitled to compensation.  Consult a trusted attorney today to discuss your rights.